A Phase I, Randomized, Observer-Blinded, Placebo-Controlled, Single and Multiple Ascending-Dose Study to Investigate the Safety, Pharmacokinetics, and Immunogenecity of BITS7201A in Healthy Volunteers and Patients With Mild Atopic Asthma
Phase of Trial: Phase I
Latest Information Update: 21 Jun 2017
At a glance
- Drugs RG-7990 (Primary) ; RG-7990 (Primary)
- Indications Allergic asthma
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Genentech
- 15 Jun 2017 Status changed from active, no longer recruiting to completed.
- 09 May 2017 Status changed from recruiting to active, no longer recruiting.
- 17 Oct 2016 Planned End Date changed from 1 Apr 2017 to 1 Jul 2017.